[Leflunomide in combination with TNF-blockers for Methotrexate intolerance]

Z Rheumatol. 2009 Mar;68(2):165-8. doi: 10.1007/s00393-008-0422-2.

[Article in German]

Authors

K Krüger¹, B Manger; die Kommission Pharmakotherapie der DGRh

Affiliation

¹ Praxiszentrum St. Bonifatius, St. Bonifatius Str. 5, 81541 München. Klaus.Krueger@med.uni-muenchen.de

PMID: 19159938
DOI: 10.1007/s00393-008-0422-2

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Antibodies, Monoclonal / administration & dosage*
Antirheumatic Agents / administration & dosage*
Arthritis, Rheumatoid / drug therapy*
Drug Resistance
Drug Therapy, Combination
Humans
Isoxazoles / administration & dosage*
Leflunomide
Methotrexate / therapeutic use*
Tumor Necrosis Factor Inhibitors*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Antibodies, Monoclonal
Antirheumatic Agents
Isoxazoles
Tumor Necrosis Factor Inhibitors
Leflunomide
Methotrexate